An arsenal of new Alzheimer's research indicates that beta-amyloid plaque in the brain not only is involved in the pathology of Alzheimer's disease but may also precede even mild cognitive decline. These and other studies advance molecular imaging for the early detection of beta-amyloid, for which one product is now approved in the United States, as a major push forward in the race for better treatments.
- Molecular imaging detects first signs of Alzheimer's diseaseMon, 7 Jun 2010, 17:03:00 EDT
- Alzheimer's-like brain changes found in cognitively normal elders with amyloid plaquesWed, 30 Mar 2011, 11:03:05 EDT
- Impaired energy metabolism linked with initiation of plaques in Alzheimer's brainWed, 24 Dec 2008, 12:57:23 EST
- Alzheimer's patients show striking individual differences in molecular basis of diseaseThu, 12 Sep 2013, 15:12:28 EDT
- Alzheimer's memory problems originate with protein clumps floating in the brain, not amyloid plaquesTue, 27 Apr 2010, 11:59:10 EDT